Introduction
Tularaemia is an enzootic disease of the northern hemisphere caused by the Gram-negative coccoid bacterium Francisella tularensis. Although considered as a rare disease, increasing numbers of human cases often associated with local outbreaks have been reported from Europe in recent years. 1 -3 Infection is acquired by handling infected small mammals (mostly hares and rodents), but may also be contracted by ingestion, by arthropod bites and via the aerosol or waterborne route of transmission. Ulceroglandular, glandular and oropharyngeal tularaemia are by far the most clinical forms of the disease in Europe. 1, 4, 5 Elevated awareness and improved diagnostic capabilities may to some extent account for increased incidence, but because of the cyclic nature of tularaemia, larger outbreaks will occur periodically.
In contrast to North America, where F. tularensis subsp. tularensis, a category A agent with a low infective dose, is the predominant disease-causing agent, in Europe the less virulent F. tularensis subsp. holarctica (also referred to as Jellison type B) is responsible for most of the infections. 6 Streptomycin, gentamicin, chloramphenicol, tetracycline and quinolones are established antibiotics in the therapy of tularaemia. 6 -9 Published data of antimicrobial in vitro testing have often focused on F. tularensis subsp. tularensis and subsp. holarctica. 10 -12 Nonetheless, Francisella philomiragia and F. tularensis subsp. novicida are capable of infecting humans, particularly with regard to immunocompromised patients, and even with fatal outcome. 13, 14 Moreover, different assays and media have been used in recent decades, 8,10,11,15 -17 and results in a standardized Recommendations for post-exposure prophylaxis and empirical therapy have to be based on in-depth knowledge of reliable susceptibility results of clinical and wild-type isolates. Therefore, there is a need to extend the data records for European strains of F. tularensis as well as rare Francisella species compiled by a standardized methodology.
Materials and methods

Bacterial strains
Ninety-one strains of Francisella spp. [20 from Germany, 26 from Austria, 5 from France and 40 from other European and non-European countries; see Table 1 and Table S1 (available as Supplementary data at JAC Online)] isolated from human and animal cases or environmental samples were selected from the culture collection of the German reference laboratory for tularaemia (Bundeswehr Institute of Microbiology, Munich). All isolates, which were long-term stored at 2808C in Microbank TM cryovials (Pro-Lab Diagnostics, Richmond Hill, Canada), were spread on cystine heart agar plates (BD, Heidelberg, Germany) and passaged once after 48-72 h of incubation at 378C and in a 5% CO 2 atmosphere before antibiotic susceptibility testing was performed.
Confirmation of identity
Total DNA was purified from typical colonies using a commercial kit based on silica gel membrane technology (DNeasy Blood & Tissue Kit, Qiagen, Hilden, Germany). Affiliation to the genus Francisella and identification of species and subspecies was done by amplification of the 16S rRNA gene of F. tularensis (LightMix w Kit F. tularensis, TIB MOLBIOL, Berlin, Germany) followed by conventional PCRs targeting a 30 bp deletion in the Ft-M19 locus and the region of differentiation 1 ('RD1'). As described previously, strains of F. philomiragia were confirmed by fluorescent in situ hybridization, 19 while Francisella hispaniensis was verified by 16S rRNA and recA gene sequencing. 20 The majority of strains belonged to F. tularensis subsp. holarctica (69 isolates). The remaining isolates belonged to other members of the genus Francisella, such as F. tularensis subsp. tularensis (seven isolates), F. tularensis subsp. mediasiatica (four isolates), F. tularensis subsp. novicida (four isolates), F. hispaniensis (one isolate) and F. philomiragia (six isolates, including two from Europe). For quality control purposes, Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 29213 and Pseudomonas aeruginosa ATCC 27853 were also tested as described by Brown et al.
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Antimicrobial substances
For antibiotic susceptibility testing the commercially available CE-certified MICRONAUT-S microtitre broth dilution testing system (Merlin, BornheimHersel, Germany) was used. The 96-well microtitre plates were customized according to the specifications of our institute. Each plate contained a 2-fold serial dilution of the following antibiotics: amikacin (0. 
Pre-tests
Prior to MIC determination, time of incubation (24 versus 48 h) and inoculum concentration as key variables were tested for their influence on the MIC values.
MIC determination
Final testing conditions were in accordance with the current recommendations of the CLSI. 22 We used the direct colony suspension method for inoculum preparation. Single colonies were picked from agar plates and inoculated in physiological saline until the turbidity matched that of a 0.5 McFarland standard. The suspension was diluted 56-fold in cation-adjusted Mueller-Hinton broth (pH¼7.1+0.1) to which a 2% growth supplement [25.9 g of L-cysteine hydrochloride, 1.1 g of L-cystine, 1.0 g of adenine, 0.03 g of guanine hydrochloride, 0.01 g of vitamin B 12 , 0.1 g of cocarboxylase, 0.25 g of NAD, 10.0 g of L-glutamine, 0.02 g of ferric nitrate, 100 g of glucose, 0.003 g of thiamine hydrochloride and 13 mg of para-aminobenzoic acid (in 1 L of H 2 O)] was added after autoclaving. The final inoculum was 100mL of a suspension that contained 8×10 5 cfu/mL. The MICs were determined after incubation for 24 and 48 h at 378C in a 5% CO 2 atmosphere. Bacterial growth was monitored photometrically at a wavelength of 620 nm. The reading was carried out with a photometer (MERLIN, Bornheim-Hersel, Germany) 22 and published data, 18 we additionally compiled MIC results for a subset of F. tularensis subsp. holarctica strains with a pH value of the medium of 7.3 + 0.1.
Results
The MIC results for quality control strains were in the appropriate quality control range according to Table 18D of CLSI M45-A2. 22 For Francisella ssp., readings after 24 h often led to two to three times lower log 2 dilution MIC results compared with those read after 48 h. However, provided that the growth control indicated clear-cut turbidity, reliable results in the tripartite classification scheme (susceptible/intermediate/resistant) could be read out with the spectrophotometer after 24 h. Differences between the pH 7.1 and pH 7.3 groups were within the random deviation of the broth microdilution method of one log 2 dilution. In contrast, inoculum concentration was a crucial variable. A 10-fold increase in the inoculum concentration led to higher MICs, whereas a decrease by 10-fold led to lower MICs, and thereby to very major errors in the interpretation of the results.
The MIC distributions for all F. tularensis subsp. holarctica isolates are listed in Table 2 . All strains were susceptible to aminoglycosides, quinolones, tetracycline and chloramphenicol according to the CLSI breakpoints. We observed no differences with regard to the source of the strains (human, animal or environmental samples). A geographical distribution was observed for erythromycin only. We observed two geographically distinct groups of F. tularensis subsp. holarctica isolates: on the one hand, highly erythromycin-resistant strains originated predominantly from the northern and eastern parts of Europe (Austria and Sweden); and on the other hand, susceptible strains originated from western and southern Europe (France, Switzerland and Spain). Remarkably both groups could be found only in strains isolated in Germany.
Rare Francisella species and subspecies did not differ in their MIC ranges more than one doubling dilution compared with type B strains (see Table 3 ). The lowest MIC results were observed for quinolones, but all strains were also susceptible to The streptomycin susceptibility breakpoint is ≤16 mg/L when the test is incubated in CO 2 and ≤8 mg/L when incubated in air. 
Discussion
Standardization is the most challenging factor for reliable and reproducible results in the field of antimicrobial susceptibility testing. Having no specific European recommendations for testing of agents of bioterrorism, the CLSI provides a method, testing conditions and breakpoints with international approval.
As proper preparation and dilution of the antimicrobial agents are key components to the criterion standard 'broth dilution testing', we used a commercially available CE-certified system with standardized lyophilized antibiotics. The results of the quality control strains as well as the reproducibility of the Francisella strains confirmed the accuracy of this system. We customized the broth microdilution system according to the specifications of our diagnostic division: to cover a broad spectrum of bacteria and appropriate antimicrobial drugs. As a consequence, we had to narrow the investigated MIC ranges. Thus our results allow a reliable therapeutic conclusion, but only a limited prediction for the MIC distribution of the Francisella wild-type population.
The MIC is defined as the lowest concentration of a given antimicrobial substance that inhibits visible growth in the in vitro testing. Nowadays most laboratories use spectrophotometers to read out the test results, because it is a more efficient and less subjective method compared with a manual readout. However, there is no consensus about an equivalent to 'no visible growth'. We compared automatic to manual readout and found an optical density of ,0.150 at a wavelength of 620 nm after 48 h to be the best equivalent to 'no visible growth' for Francisella strains.
Our data confirm the inoculum concentration to be a critical variable of the broth microdilution method. Therefore, determination of the final inoculum concentration is mandatory before implementation of that susceptibility testing method into routine laboratory operation. 23 In contrast, slight fluctuations in the pH value between 7.1 and 7.3 of the medium did not affect the MIC results or the interpretative category for all 14 antibiotics used in this study.
Due to the fastidious growth requirements of Francisella, the standard incubation time was ruled to be 48 h by the CLSI, but Etests often need more than 2 days for a clear-cut result. In our experience, slight turbidity of the broth indicating growth can be measured with a spectrophotometer many hours before growth is detected by an unaided eye after 48 h. Our data stress that quantitative MIC results obtained by spectrometric examination after 24 h are preliminary and have to be confirmed after 48 h. Multiple automated readings and growth kinetic assays could be a possible way to obtain reliable MIC results earlier.
MICs observed were consistent with the Etest method, clinical experience and other published data of studies investigating susceptibility patterns of F. tularensis. 8,10 -12,16,18 The data affirm that b-lactam antibiotics and co-trimoxazole are not suitable for therapy of tularaemia. Because of concern about development of resistance during therapy, rifampicin is not recommended, 6 although the substance is active in vitro. F. tularensis subsp. holarctica showed a bimodal MIC distribution for erythromycin, which could be attributed to the geographical origin of the particular strain. The latest case reports from Turkey and France stress therapeutic failure or relapses due to macrolide therapy. 2, 5 Thus erythromycin is also not a reliable option in cases of tularaemia in Europe, even in areas where the susceptible biovar I is endemic. Although some authors suggest ketolides for therapy, 24 cross-resistance to macrolides occurs on a regular basis (E. Georgi and W. D. Splettstoesser, unpublished data) and should be considered. In contrast, commonly used substances like aminoglycosides, tetracyclines, quinolones and chloramphenicol showed high in vitro activities across all Francisella species and subspecies. To the best of our knowledge, our study on the antimicrobial susceptibility of the rare F. hispaniensis, F. philomiragia and F. tularensis subsp. novicida strains provides the first data regarding these pathogens, which can occasionally cause severe infections in humans, especially in immunocompromised hosts. All strains in this study were susceptible to aminoglycosides, tetracycline, quinolones and chloramphenicol. A species-specific susceptibility pattern could not be observed. These results bring into question the requirement for susceptibility testing at all. But resistance can be easily created in vitro by performing serial cultures in the presence of increasingly high concentrations of a given antimicrobial. 24 Moreover, multidrug-resistant Francisella strains were stockpiled during the Cold War and could be used in a bioterror or biocrime scenario. Therefore, testing of clinical isolates with standardized methodology should always be performed.
In conclusion, our study provides reliable data of antibiotic susceptibility patterns of European F. tularensis subsp. holarctica isolates. The microtitre broth dilution system with lyophilized antibiotics proved to be a valuable and reliable method even in a BSL 3 containment.
